Century Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Other funds holding GBT
PA
O
ACA
Century Capital Management's GBT Position: Q2 2017 in Review
Century Capital Management reduced its Global Blood Therapeutics, Inc. (GBT) stake by 43% in Q2 2017, selling an estimated $1.52M and leaving 68,843 shares worth $1.88M. The position accounts for 0.32% of the portfolio, ranked #106.
Century Capital Management first reported a position in GBT in Q3 2016 and has held it in 4 quarters since. The position peaked at $4.42M in Q1 2017. 134 funds tracked by Wall St. Rank hold GBT as of Q2 2017.
- Century Capital Management held 68,843 shares of Global Blood Therapeutics, Inc. worth $1.88M as of Q2 2017.
- Century Capital Management sold 51,104 Global Blood Therapeutics, Inc. shares in Q2 2017, an estimated $1.52M.
- Global Blood Therapeutics, Inc. made up 0.32% of Century Capital Management's portfolio in Q2 2017, its #106 holding.
- Century Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2016 and has held it in 4 quarters since.
- Century Capital Management's Global Blood Therapeutics, Inc. position peaked at $4.42M in Q1 2017.
- 134 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2017.
Based on Century Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.